Related Experiment Video

Updated: May 8, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Antithrombotic therapy in patients with acute coronary syndromes: how to make the right choice?

A Eitan1, E Nikolsky

  • 1Cardiology Department Rambam Health Care Campus and Technion-Israel Institute of TechnologyHaifa, Israel - e_nikolsky@rambam.health.gov.il.

Minerva Medica
|September 7, 2013
PubMed

Insights

Acute coronary syndrome (ACS) involves plaque rupture and thrombosis. This review analyzes antiplatelet and antithrombotic therapies, balancing benefits and risks for patients with ACS.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Acute coronary syndrome (ACS) is a major cause of hospital admission and mortality.
  • ACS involves atherosclerotic plaque rupture and thrombus formation via platelets and coagulation.
  • Effective treatment requires balancing therapeutic benefits against bleeding risks.

Purpose of the Study:

  • To provide a comprehensive analysis of current antiplatelet and antithrombotic therapies for ACS.
  • To discuss the development of pharmacological agents for plaque stabilization and thrombosis inhibition.
  • To highlight the importance of optimizing benefit-risk profiles in ACS treatment.

Main Methods:

  • Literature review of pharmacological agents and clinical outcomes in ACS.
  • Analysis of mechanisms of action for antiplatelet and antithrombotic drugs.
  • Evaluation of therapeutic strategies in acute ACS and secondary prevention.

Main Results:

  • Platelet activation and coagulation cascade are critical in ACS thrombus formation.
  • Pharmacological agents aim to stabilize plaques and inhibit thrombosis.
  • Balancing antithrombotic efficacy with bleeding risk is paramount.

Conclusions:

  • Antiplatelet and antithrombotic therapies are essential in managing ACS.
  • Ongoing research focuses on developing safer and more effective treatments.
  • Individualized risk-benefit assessment is crucial for optimal patient management in ACS.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...